What is the appropriate epinephrine dosage for a severe allergic reaction (anaphylaxis)?

Epinephrine Dosage for Severe Allergic Reactions (Anaphylaxis)

For severe allergic reactions (anaphylaxis), administer epinephrine 0.3-0.5 mg intramuscularly (IM) in adults and 0.01 mg/kg (maximum 0.3 mg) in children, injected into the anterolateral thigh, and repeat every 5-15 minutes as needed. 1, 2

Dosing by Weight and Age

Adults and Children ≥30 kg (66 lbs)

• Dose: 0.3-0.5 mg (0.3-0.5 mL of 1:1000 solution) IM 1, 2
• Route: Intramuscular injection into the lateral thigh (vastus lateralis) 1
• Repeat: Every 5-15 minutes as necessary 1
• Autoinjector equivalent: 0.3 mg dose 1

Children <30 kg (66 lbs)

• Dose: 0.01 mg/kg (0.01 mL/kg of 1:1000 solution), maximum 0.3 mg 1, 2
• Route: Intramuscular injection into the lateral thigh 1
• Repeat: Every 5-15 minutes as necessary 1
• Autoinjector dosing: 0.15 mg for children 15-30 kg; 0.1 mg formulations available for infants >7.5 kg 1

Infants

• Dose: 0.01 mg/kg IM 1
• Practical consideration: While 0.15 mg autoinjectors deliver higher doses for smaller infants (<7.5 kg), the speed and precision of autoinjectors may justify this trade-off compared to drawing up doses manually 1

Route of Administration

Intramuscular injection into the anterolateral thigh (vastus lateralis) is the preferred and only recommended route for first-aid treatment of anaphylaxis. 1

• IM injection in the thigh produces rapid peak plasma epinephrine concentrations 1
• Never inject into buttocks, digits, hands, or feet 2
• Subcutaneous administration is inferior and not recommended for anaphylaxis 1

Repeat Dosing

Many patients require multiple doses of epinephrine—be prepared to administer additional doses. 1

• 6-19% of pediatric patients require a second dose 1
• Overall, 35% of anaphylaxis patients may need more than one dose 3
• Severe reactions (Grade III) require multiple doses in 72% of cases 3
• There is no absolute contraindication to epinephrine use in anaphylaxis 1, 2

Intravenous Epinephrine (Advanced Settings Only)

IV epinephrine should only be used in cardiac arrest or profoundly hypotensive patients who fail to respond to IM epinephrine and volume resuscitation. 1

For Anaphylactic Shock (Not in Cardiac Arrest)

• Dose: 0.05-0.1 mg (5-10 mL of 1:10,000 solution) IV bolus 1
• Alternative: IV infusion at 1-10 mcg/min, titrated to response 1
• Critical requirement: Continuous hemodynamic monitoring is essential 1
• Risk: Potentially lethal arrhythmias 1

For Cardiac Arrest from Anaphylaxis

• Initial dose: 1-3 mg (1:10,000 dilution) IV over 3 minutes 1
• Escalation: 3-5 mg IV over 3 minutes, then 4-10 mg/min infusion 1
• Pediatric cardiac arrest: 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution) every 3-5 minutes 1

Critical Management Points

Timing is Everything

• Administer epinephrine immediately upon recognition of anaphylaxis 1, 4
• Delays in administration may be fatal 4, 5
• Epinephrine is underutilized and often dosed suboptimally 5

Adjunctive Therapies (Second-Line Only)

Never delay or substitute epinephrine with antihistamines or corticosteroids. 1

• H1 antihistamines (diphenhydramine 1-2 mg/kg or 25-50 mg): Second-line for cutaneous symptoms only 1
• H2 antihistamines (ranitidine 1 mg/kg): May be added to H1 blockers but slower onset than epinephrine 1
• Corticosteroids: No proven role in acute treatment; may help prevent protracted reactions but should not delay epinephrine 1
• Inhaled beta-agonists: For bronchospasm resistant to epinephrine 1

Additional Interventions

• Position: Place patient supine with elevated lower extremities (unless respiratory distress/vomiting present) 1
• IV fluids: Administer early with first epinephrine dose for cardiovascular involvement 1
• Oxygen: For respiratory distress and patients requiring multiple epinephrine doses 1
• Call EMS immediately in all cases of anaphylaxis 1

Common Pitfalls to Avoid

1. Delaying epinephrine administration while trying antihistamines or corticosteroids first 1, 5
2. Using subcutaneous instead of intramuscular route 1
3. Injecting into wrong anatomical sites (buttocks, arms) instead of lateral thigh 2
4. Underdosing or failing to repeat doses when symptoms persist 1, 3
5. Withholding epinephrine due to perceived contraindications—there are none in anaphylaxis 1, 2
6. Inadequate observation periods—monitor for at least 2-4 hours for biphasic reactions 1, 6, 7

Special Populations

Patients on Beta-Blockers

• May have refractory hypotension and bradycardia 1
• Consider glucagon: 1-5 mg IV over 5 minutes, followed by 5-15 mcg/min infusion 1
• Glucagon dosing in children: 20-30 mcg/kg (maximum 1 mg) 1

Pregnant Women and Elderly

• May be at greater risk for adverse reactions with parenteral epinephrine 2
• However, benefits outweigh risks in anaphylaxis—do not withhold 1, 2